Get the Stockscreener App
12.99
2.28%
0.29
Benitec Biopharma Inc stock is traded at $12.99, with a volume of 74,167.
It is up +2.28% in the last 24 hours and up +15.36% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$12.70
Open:
$12.83
24h Volume:
74,167
Relative Volume:
0.68
Market Cap:
$340.99M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.1861
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
-0.15%
1M Performance:
+15.36%
6M Performance:
+14.96%
1Y Performance:
+44.33%
1-Day Range:
$12.70
$13.19
1-Week Range:
$12.34
$13.19
52-Week Range:
$8.06
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
12.99 | 333.64M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | TD Cowen | Buy |
| Dec-16-24 | Initiated | H.C. Wainwright | Buy |
| Dec-13-24 | Initiated | Robert W. Baird | Outperform |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Sep-12-24 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Piper Sandler | Overweight |
| Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-31-15 | Reiterated | Maxim Group | Buy |
| Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
Is Benitec Biopharma Inc. building a consolidation baseEarnings Miss & Verified Trade Idea Suggestions - Newser
Why Benitec Biopharma Inc. is moving todayQuarterly Portfolio Report & Expert Approved Momentum Ideas - Newser
How to track smart money flows in Benitec Biopharma Inc.Market Sentiment Review & Weekly High Return Stock Forecasts - Newser
What’s next for Benitec Biopharma Inc. stock price2025 Price Action Summary & Momentum Based Trading Ideas - Newser
Tick level data insight on Benitec Biopharma Inc. volatilityShort Setup & Fast Gain Stock Trading Tips - Newser
What makes Benitec Biopharma Inc. stock price move sharply - Newser
Is this a good reentry point in Benitec Biopharma Inc.Weekly Trade Recap & Real-Time Stock Movement Alerts - Newser
Using data models to predict Benitec Biopharma Inc. stock movementEarnings Miss & Verified Trade Idea Suggestions - Newser
News impact scoring models applied to Benitec Biopharma Inc.2025 Top Gainers & Low Risk Entry Point Guides - Newser
Using R and stats models for Benitec Biopharma Inc. forecasting2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - Newser
Applying chart zones and confluence areas to Benitec Biopharma Inc.Analyst Upgrade & Breakout Confirmation Alerts - Newser
Is it time to cut losses on Benitec Biopharma Inc.Portfolio Gains Summary & Expert Curated Trade Setups - Newser
Will Benitec Biopharma Inc. continue its uptrendTreasury Yields & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-18 03:57:28 - Newser
Real time scanner hits for Benitec Biopharma Inc. explained2025 Volatility Report & AI Powered Market Trend Analysis - Newser
What data driven models say about Benitec Biopharma Inc.’s futureQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
How to recover losses in Benitec Biopharma Inc. stockWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Will Benitec Biopharma Inc. Stock Benefit from AI and Green Energy TrendsJuly 2025 Technicals & Low Risk Entry Point Guides - Newser
We're Interested To See How Benitec Biopharma (NASDAQ:BNTC) Uses Its Cash Hoard To Grow - Yahoo Finance
How Benitec Biopharma Inc. stock performs during market volatilityMarket Performance Recap & Safe Capital Growth Tips - thegnnews.com
Why Benitec Biopharma Inc. stock attracts strong analyst attentionWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - Newser
What machine learning models say about Benitec Biopharma Inc.Weekly Trend Recap & Smart Money Movement Tracker - Newser
How to forecast Benitec Biopharma Inc. trends using time seriesJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Tools to assess Benitec Biopharma Inc.’s risk profileJuly 2025 Retail & Technical Pattern Alert System - Newser
Predicting Benitec Biopharma Inc. trend using moving averages2025 Bull vs Bear & Smart Money Movement Alerts - Newser
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Benitec Biopharma Inc Stock (BNTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):